Published in Blood Weekly, May 3rd, 2012
"Recipients were stratified into a low MELD score group (Group L; MELD score <= 30) and a high MELD score group (Group H; MELD score >30) to compare short-term and long-term outcomes. Of the 152 adult patients who underwent A-A LDLT, 9...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.